预测和预防2型糖尿病中的心力衰竭
该综述讨论2型糖尿病中心力衰竭的病理生理学和危险因素,回顾预测心力衰竭发生率的风险评估工具以及评估生活方式和药物干预疗效的临床试验数据,并讨论实施新管理方法的潜在挑战及提供实用建议。
要点
- 2型糖尿病合并心力衰竭患者住院率和死亡率更高,需实施最佳预防策略。
- 理解病理生理学有助于识别危险因素并早期干预以预防心力衰竭。
- 综述涵盖风险评估工具及生活方式和药物干预的临床试验证据。
核心结论
- 对2型糖尿病患者实施最佳心力衰竭预防策略至关重要。
研究设计与样本
- 综述,讨论2型糖尿病中心力衰竭的病理生理学、危险因素、风险评估工具及临床试验数据,并讨论实施挑战和提供实用建议。
主要发现
- 2型糖尿病合并心力衰竭患者结局更差,如住院率和死亡率更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The burden of heart failure among people with type 2 diabetes is increasing globally. People with comorbid type 2 diabetes and heart failure often have worse outcomes than those with only one of these conditions-eg, higher hospitalisation and mortality rates. Therefore, it is essential to implement optimal heart failure prevention strategies for people with type 2 diabetes. A detailed understanding of the pathophysiology underlying the occurrence of heart failure in type 2 diabetes can aid clinicians in identifying relevant risk factors and lead to early interventions that can help prevent heart failure. In this Review, we discuss the pathophysiology and risk factors of heart failure in type 2 diabetes. We also review the risk assessment tools for predicting heart failure incidence in people with type 2 diabetes as well as the data from clinical trials that have assessed the efficacy of lifestyle and pharmacological interventions. Finally, we discuss the potential challenges in implementing new management approaches and offer pragmatic recommendations to help overcome these challenges.
引用
- Pandey A, Khan MS, Patel KV, et al. Predicting and preventing heart failure in type 2 diabetes. Lancet Diabetes Endocrinol. 2023. PMID: 37385290. doi:10.1016/S2213-8587(23)00128-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。